Japan has approved pioneering stem-cell treatments for Parkinson's and severe heart failure, marking a global first in commercially available medical products using iPS cells.

Japan has approved the world’s first stem cell therapy for Parkinson’s disease, offering new hope for millions globally. The treatment uses induced pluripotent stem (iPS) cells to replace damaged ...

Japan has formally approved the world’s first regenerative medical products utilizing induced pluripotent stem (iPS) cells, paving the way for use in patients as early as this summer.

Pharmaceutical company Sumitomo Pharma said it received the green light for the manufacture and sale of Amchepry, its ...

Japan's health ministry has announced formal approval for the domestic manufacture and sale of two products for the treatment of heart disease and Parkinson's disease using iPS cells. It means such ...

The Japanese government on Friday conditionally approved the commercialization of two regenerative medicine products prepared ...

A Parkinson's disease treatment based on induced pluripotent stem cells (iPS) has been officially approved in Japan – as announced by ...

Japan's health ministry said Friday it has conditionally approved the production and sales of two regenerative medical products using induced pluripotent stem cells. The approval was given to ...

Japan's health ministry said Friday it has conditionally approved production and sales of two novel regenerative therapies capitalizing on induced pluripotent stem cells. The world's first permission ...

Japan has approved the world’s first stem-cell treatment for Parkinson’s disease, offering new hope for patients living with ...

The Japanese government on Friday conditionally approved the commercialization of two regenerative medicine products prepared from induced pluripotent ...